# FDA Inspection 1168977 - Isabel Leroux-Roels, M.D, PhD. - April 27, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/isabel-leroux-roels-md-phd/fdacd817-8f36-49ab-bf17-75f20b15fe6a/
Source feed: FDA_Inspections

> FDA Inspection 1168977 for Isabel Leroux-Roels, M.D, PhD. on April 27, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168977
- Company Name: Isabel Leroux-Roels, M.D, PhD.
- Inspection Date: 2022-04-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168977 - 2022-04-27](https://www.globalkeysolutions.net/api/records/fda_inspections/isabel-leroux-roels-md-phd/751bf868-85f1-466d-a487-d28b3a60c45e/)

Company: https://www.globalkeysolutions.net/companies/isabel-leroux-roels-md-phd/c6c2adab-9333-4202-8ec1-28231ae4414e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d